These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32199878)

  • 1. Inflammatory Bowel Disease Clusters Within Affected Sibships in Ashkenazi Jewish Multiplex Families.
    Spencer EA; Helmus D; Telesco S; Colombel JF; Dubinsky MC;
    Gastroenterology; 2020 Jul; 159(1):381-382. PubMed ID: 32199878
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of inflammatory bowel disease in family members of Jewish Crohn's disease patients in Israel.
    Zlotogora J; Zimmerman J; Rachmilewitz D
    Dig Dis Sci; 1991 Apr; 36(4):471-5. PubMed ID: 2007363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory bowel disease: an emergent disease among Ethiopian Jews migrating to Israel.
    Bar-Gil Shitrit A; Koslowsky B; Kori M; Paz K; Adar T; Israeli E; Ben-Horin S; Berdichevski T; Coscas D; Gal E; Odes S; Shaul R; Ben-Ya'acov A; Goldin E
    Inflamm Bowel Dis; 2015 Mar; 21(3):631-5. PubMed ID: 25581835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of the MTHFR C677T polymorphism with inflammatory bowel diseases in the Israeli Jewish population: An example of genetic heterogeneity.
    Karban A; Feldman T; Waterman M; Leiba R; Efrati E
    Medicine (Baltimore); 2016 Dec; 95(51):e5611. PubMed ID: 28002332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare coding variant analysis in a large cohort of Ashkenazi Jewish families with inflammatory bowel disease.
    Schiff ER; Frampton M; Ben-Yosef N; Avila BE; Semplici F; Pontikos N; Bloom SL; McCartney SA; Vega R; Lovat LB; Wood E; Hart A; Israeli E; Crespi D; Furman MA; Mann S; Murray CD; Segal AW; Levine AP
    Hum Genet; 2018 Sep; 137(9):723-734. PubMed ID: 30167848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low prevalence of the APC I1307K sequence in Jewish and non-Jewish patients with inflammatory bowel disease.
    Yin J; Harpaz N; Souza RF; Zou T; Kong D; Wang S; Leytin AL; Medalie NS; Smolinski KN; Abraham JM; Fleisher AS; Meltzer SJ
    Oncogene; 1999 Jul; 18(26):3902-4. PubMed ID: 10445854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic Jews with Crohn's disease.
    Karban A; Waterman M; Panhuysen CI; Pollak RD; Nesher S; Datta L; Weiss B; Suissa A; Shamir R; Brant SR; Eliakim R
    Am J Gastroenterol; 2004 Jun; 99(6):1134-40. PubMed ID: 15180737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the risk that a child will develop inflammatory bowel disease if 1 or both parents have IBD?
    Noble CL; Arnott ID
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S22-3. PubMed ID: 18816708
    [No Abstract]   [Full Text] [Related]  

  • 9. The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population.
    Foulkes WD; Thiffault I; Gruber SB; Horwitz M; Hamel N; Lee C; Shia J; Markowitz A; Figer A; Friedman E; Farber D; Greenwood CM; Bonner JD; Nafa K; Walsh T; Marcus V; Tomsho L; Gebert J; Macrae FA; Gaff CL; Paillerets BB; Gregersen PK; Weitzel JN; Gordon PH; MacNamara E; King MC; Hampel H; De La Chapelle A; Boyd J; Offit K; Rennert G; Chong G; Ellis NA
    Am J Hum Genet; 2002 Dec; 71(6):1395-412. PubMed ID: 12454801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune diseases in first- and second-degree relatives of patients with inflammatory bowel diseases: a case-control survey in Israel.
    Mari A; Khoury T; Ahamad HS; Bragazzi NL; Sbeit W; Mahamid A; Mahamid L; Nesseir W; Baker FA; Pellicano R; Amital H; Watad A; Mahamid M
    Minerva Med; 2020 Apr; 111(2):107-114. PubMed ID: 31828987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying high-impact variants and genes in exomes of Ashkenazi Jewish inflammatory bowel disease patients.
    Wu Y; Gettler K; Kars ME; Giri M; Li D; Bayrak CS; Zhang P; Jain A; Maffucci P; Sabic K; Van Vleck T; Nadkarni G; Denson LA; Ostrer H; Levine AP; Schiff ER; Segal AW; Kugathasan S; Stenson PD; Cooper DN; Philip Schumm L; Snapper S; Daly MJ; Haritunians T; Duerr RH; Silverberg MS; Rioux JD; Brant SR; McGovern DPB; Cho JH; Itan Y
    Nat Commun; 2023 Apr; 14(1):2256. PubMed ID: 37080976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effect.
    Shtoyerman-Chen R; Friedman E; Figer A; Carmel M; Patael Y; Rath P; Fidder HH; Bar-Meir S; Theodor L
    Genet Test; 2001; 5(2):141-6. PubMed ID: 11551102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The IBD1 locus for susceptibility to Crohn's disease has a greater impact in Ashkenazi Jews with early onset disease.
    Akolkar PN; Gulwani-Akolkar B; Lin XY; Zhou Z; Daly M; Katz S; Levine J; Present D; Gelb B; Desnick R; Mayer L; Silver J
    Am J Gastroenterol; 2001 Apr; 96(4):1127-32. PubMed ID: 11316159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucolipidosis type IV a rare genetic disorder: new addition to the Ashkenazi Jewish panel.
    Gordon RM; Marchese T
    J Midwifery Womens Health; 2004; 49(4):359-60. PubMed ID: 15236718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial empiric risk estimates of inflammatory bowel disease in Ashkenazi Jews.
    Roth MP; Petersen GM; McElree C; Vadheim CM; Panish JF; Rotter JI
    Gastroenterology; 1989 Apr; 96(4):1016-20. PubMed ID: 2925048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-857 polymorphism in Israeli Jewish patients with inflammatory bowel disease.
    Fidder HH; Heijmans R; Chowers Y; Bar-Meir S; Avidan B; Pena AS; Crusius JB
    Int J Immunogenet; 2006 Apr; 33(2):81-5. PubMed ID: 16611251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethnic Variations in Inflammatory Bowel Diseases Among Israel's Populations.
    Mahamid M; Bar-Gil Shitrit A; Amara H; Koslowsky B; Ghantous R; Safadi R
    Isr Med Assoc J; 2019 Oct; 21(10):662-665. PubMed ID: 31599507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among Ashkenazi Jewish Women.
    Walsh T; Mandell JB; Norquist BM; Casadei S; Gulsuner S; Lee MK; King MC
    JAMA Oncol; 2017 Dec; 3(12):1647-1653. PubMed ID: 28727877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change in Prevalence of Family History During Long-term Follow-up of Patients With Pediatric-onset Inflammatory Bowel Disease.
    Capone K; Rosenberg HJ; Wroblewski K; Gokhale R; Kirschner BS
    J Pediatr Gastroenterol Nutr; 2019 Jun; 68(6):829-834. PubMed ID: 30628987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families.
    Stadler ZK; Saloustros E; Hansen NA; Schluger AE; Kauff ND; Offit K; Robson ME
    Breast Cancer Res Treat; 2010 Sep; 123(2):581-5. PubMed ID: 20221693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.